165.98
price up icon0.72%   1.18
pre-market  プレマーケット:  164.99   -0.99   -0.60%
loading
前日終値:
$164.80
開ける:
$165
24時間の取引高:
1.13M
Relative Volume:
0.76
時価総額:
$13.40B
収益:
$8.19B
当期純損益:
$758.19M
株価収益率:
18.08
EPS:
9.18
ネットキャッシュフロー:
$1.06B
1週間 パフォーマンス:
-10.38%
1か月 パフォーマンス:
+10.58%
6か月 パフォーマンス:
-15.49%
1年 パフォーマンス:
-46.54%
1日の値動き範囲:
Value
$163.76
$168.16
1週間の範囲:
Value
$162.99
$186.37
52週間の値動き範囲:
Value
$125.10
$328.35

Icon Plc Stock (ICLR) Company Profile

Name
名前
Icon Plc
Name
セクター
Healthcare (1162)
Name
電話
-
Name
住所
-
Name
職員
39,900
Name
Twitter
@ICONplc
Name
次回の収益日
2025-07-23
Name
最新のSEC提出書
Name
ICLR's Discussions on Twitter

ICLR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
ICLR
Icon Plc
165.98 12.82B 8.19B 758.19M 1.06B 9.18
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
466.42 176.18B 43.21B 6.58B 6.17B 17.29
Diagnostics & Research icon
DHR
Danaher Corp
199.04 141.39B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
641.94 54.91B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
114.89 32.62B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
183.93 31.07B 15.50B 1.33B 2.16B 7.34

Icon Plc Stock (ICLR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-24 アップグレード Robert W. Baird Neutral → Outperform
2025-04-29 ダウングレード JP Morgan Overweight → Neutral
2025-04-14 ダウングレード TD Cowen Buy → Hold
2025-04-10 ダウングレード Barclays Overweight → Equal Weight
2025-03-21 ダウングレード Goldman Buy → Neutral
2025-01-07 開始されました RBC Capital Mkts Outperform
2024-10-24 ダウングレード Robert W. Baird Outperform → Neutral
2024-10-14 開始されました Redburn Atlantic Neutral
2024-09-18 開始されました Leerink Partners Outperform
2024-06-06 開始されました Goldman Buy
2023-12-15 開始されました Truist Buy
2023-09-13 開始されました TD Cowen Outperform
2023-01-17 アップグレード Barclays Equal Weight → Overweight
2023-01-13 アップグレード Barclays Equal Weight → Overweight
2022-11-09 アップグレード BofA Securities Neutral → Buy
2022-09-07 開始されました UBS Buy
2022-08-25 開始されました Credit Suisse Neutral
2022-05-24 開始されました Guggenheim Buy
2022-04-25 ダウングレード Wells Fargo Overweight → Equal Weight
2022-04-12 アップグレード Deutsche Bank Hold → Buy
2021-09-27 アップグレード JP Morgan Neutral → Overweight
2021-08-05 再開されました Credit Suisse Outperform
2021-07-23 アップグレード Citigroup Neutral → Buy
2021-07-14 開始されました Citigroup Neutral
2021-04-13 再開されました BofA Securities Neutral
2021-04-01 アップグレード Wells Fargo Equal Weight → Overweight
2021-03-08 アップグレード Robert W. Baird Neutral → Outperform
2021-03-03 開始されました Barclays Equal Weight
2021-03-01 アップグレード UBS Neutral → Buy
2021-02-26 アップグレード Truist Hold → Buy
2020-07-24 ダウングレード BofA Securities Buy → Neutral
2020-04-20 ダウングレード Robert W. Baird Outperform → Neutral
2020-03-26 アップグレード Barclays Equal Weight → Overweight
2020-03-02 開始されました Deutsche Bank Hold
2020-01-27 ダウングレード SunTrust Buy → Hold
2020-01-08 開始されました Wells Fargo Equal Weight
2020-01-07 開始されました Citigroup Neutral
2019-09-23 ダウングレード KeyBanc Capital Markets Overweight → Sector Weight
2019-07-26 アップグレード UBS Sell → Neutral
2019-01-25 アップグレード Mizuho Neutral → Buy
2018-10-26 アップグレード Evercore ISI In-line → Outperform
2018-10-09 開始されました UBS Sell
2018-04-03 ダウングレード Evercore ISI Outperform → In-line
2018-02-15 繰り返されました Mizuho Neutral
2018-01-19 開始されました Evercore ISI Outperform
2017-10-27 繰り返されました Barclays Equal Weight
2017-09-11 開始されました BofA/Merrill Buy
2017-07-31 アップグレード SunTrust Hold → Buy
2017-07-27 繰り返されました Mizuho Neutral
2017-06-29 アップグレード Jefferies Hold → Buy
すべてを表示

Icon Plc (ICLR) 最新ニュース

pulisher
Aug 01, 2025

Fund Update: First Pacific Advisors, LP added 417,173 shares of ICON PLC ($ICLR) to their portfolio - Quiver Quantitative

Aug 01, 2025
pulisher
Jul 30, 2025

ICON Plc’s Earnings Call: Balancing Achievements and Challenges - TipRanks

Jul 30, 2025
pulisher
Jul 30, 2025

ICON plc: Initiation of Coverage- Capitalizing On Opportunities in China, A Critical Growth Market! - smartkarma.com

Jul 30, 2025
pulisher
Jul 29, 2025

ICON Plc's Q2 Earnings Call: Balancing Growth and Challenges - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Deutsche Bank Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $210 - 富途牛牛

Jul 29, 2025
pulisher
Jul 29, 2025

Leerink Partners Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $240 - 富途牛牛

Jul 29, 2025
pulisher
Jul 28, 2025

ICON plc’s SWOT analysis: navigating challenges in CRO stock landscape By Investing.com - Investing.com India

Jul 28, 2025
pulisher
Jul 28, 2025

ICON plc’s SWOT analysis: navigating challenges in CRO stock landscape - Investing.com

Jul 28, 2025
pulisher
Jul 28, 2025

ICON's Intrinsic Value Estimated at $278, 33% Undervalued by Current Share Price - AInvest

Jul 28, 2025
pulisher
Jul 27, 2025

Icon price target raised to $225 from $173 at Mizuho - TipRanks

Jul 27, 2025
pulisher
Jul 26, 2025

ICON plc Q2 2025 Financial Results: Revenue Up 0.8%, Net Income Rises 30.7% - AInvest

Jul 26, 2025
pulisher
Jul 26, 2025

UBS Raises Icon PLC Price Target to $240, Maintains 'Buy' Rating - AInvest

Jul 26, 2025
pulisher
Jul 26, 2025

Icon PLC (ICLR) Q2 Report: Barclays Raises Price Target to $180, Maintains Equal Weight Rating - AInvest

Jul 26, 2025
pulisher
Jul 26, 2025

ICON plc Reports Strong Q2 2025 Financial Results - The Globe and Mail

Jul 26, 2025
pulisher
Jul 25, 2025

ICON plc Expands Share Repurchase Program and Resumes COVID Vaccine Study - The Globe and Mail

Jul 25, 2025
pulisher
Jul 25, 2025

ICON plcOrdinary Shares (Nasdaq:ICLR) Stock Quote - FinancialContent

Jul 25, 2025
pulisher
Jul 25, 2025

Evercore Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $240 - 富途牛牛

Jul 25, 2025
pulisher
Jul 25, 2025

A Quick Look at Today's Ratings for Icon PLC(ICLR.US), With a Forecast Between $209 to $240 - 富途牛牛

Jul 25, 2025
pulisher
Jul 25, 2025

Icon PLC (ICLR) Q2 2025 Earnings Call Highlights: Navigating Cha - GuruFocus

Jul 25, 2025
pulisher
Jul 24, 2025

Icon plc's Shares Surge 17.2% Amid Investor Optimism - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

Icon Plc Announces Kedrion IVIg 10% Study for Chronic ITP: Market Implications - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

ICON Expects $8B in Revenue for Full Year, Driven by Biotech Wins and Pharma Partnerships - AInvest

Jul 24, 2025
pulisher
Jul 24, 2025

ICON plc Announces Successful AGM Resolutions - The Globe and Mail

Jul 24, 2025
pulisher
Jul 24, 2025

ICON Stock Surge: Future Safe or Risky? - StocksToTrade

Jul 24, 2025
pulisher
Jul 24, 2025

ICON’s Unexpected Surge: What’s Behind the Jump? - timothysykes.com

Jul 24, 2025
pulisher
Jul 24, 2025

ICON Stock Up After Q2 Results Signal Growing Confidence In Biopharma Recovery - Benzinga

Jul 24, 2025
pulisher
Jul 24, 2025

A Quick Look at Today's Ratings for Icon PLC(ICLR.US), With a Forecast Between $170 to $224 - 富途牛牛

Jul 24, 2025
pulisher
Jul 24, 2025

Icon plc (ICLR) Shares Surge Over 17% Amid Investor Optimism | ICLR Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Icon Plc’s New Study on Kedrion IVIg 10% for Chronic ITP: What Investors Need to Know - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

ICON’s Earnings Beat and Strategic Moves: A Market Outlook - StocksToTrade

Jul 24, 2025
pulisher
Jul 24, 2025

RPM International Posts Better-Than-Expected Earnings, Joins ICON, MaxLinear, Nasdaq And Other Big Stocks Moving Higher On ThursdayArrive AI (NASDAQ:ARAI), ASGN (NYSE:ASGN) - Benzinga

Jul 24, 2025
pulisher
Jul 24, 2025

Growth or Bubble? Decoding the Rapid Rise of ICLR Stock - StocksToTrade

Jul 24, 2025
pulisher
Jul 24, 2025

Icon PLC Q2 Earnings Exceed Projections with $183 Million ProfitNews and Statistics - IndexBox

Jul 24, 2025
pulisher
Jul 24, 2025

S&P 500 Futures Climb in Premarket Trading; West Pharmaceutical Svcs, Icon PLC Lead - Barron's

Jul 24, 2025
pulisher
Jul 24, 2025

ICON: Lower Guidance Downside & Expanded Repurchase Plan (ICLR) - Seeking Alpha

Jul 24, 2025
pulisher
Jul 24, 2025

Icon PLC: Q2 Earnings Snapshot - CTPost

Jul 24, 2025
pulisher
Jul 24, 2025

ICON Announces Results of Annual General Meeting - BioSpace

Jul 24, 2025
pulisher
Jul 23, 2025

William Blair Maintains Icon PLC(ICLR.US) With Buy Rating - 富途牛牛

Jul 23, 2025
pulisher
Jul 23, 2025

ICON PLC reports results for the quarter ended June 30Earnings Summary - TradingView

Jul 23, 2025
pulisher
Jul 23, 2025

Icon PLC (ICLR) Q2 Earnings and Revenues Top Estimates - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

ICON plc Reports Strong Q2 2025 Financial Results and Updates Guidance - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

ICON PLC earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria

Jul 23, 2025
pulisher
Jul 23, 2025

SUI Insider Grant: President Gets 4,788 Restricted Shares at $125.06 | ICLR SEC FilingForm 6-K - Stock Titan

Jul 23, 2025
pulisher
Jul 23, 2025

ICON Reports Second Quarter 2025 Results | ICLR Stock News - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

ICON's Resilience in a Turbulent Market: A Case for Strategic Investment - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

ICON Announces Results of Annual General Meeting | ICLR Stock News - GuruFocus

Jul 23, 2025
pulisher
Jul 23, 2025

ICON Clinical Research Earnings Soar 31% as Business Wins Hit $3B, Expands $1B Buyback Program - Stock Titan

Jul 23, 2025
pulisher
Jul 22, 2025

ICON plc Stock Takes Center Stage. What’s Next? - StocksToTrade

Jul 22, 2025
pulisher
Jul 22, 2025

ICON plc’s Market Surge: Examining Strong Moves - timothysykes.com

Jul 22, 2025
pulisher
Jul 22, 2025

ICON plc Emerges as Phase 1 Clinical Trials Leader in New Benchmark Report - StocksToTrade

Jul 22, 2025
pulisher
Jul 22, 2025

ICON plc Emerges as Top Contender in Clinical Research Arena - timothysykes.com

Jul 22, 2025

Icon Plc (ICLR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research WAT
$281.19
price down icon 1.54%
$140.12
price up icon 2.60%
diagnostics_research DGX
$173.27
price up icon 0.48%
diagnostics_research LH
$263.48
price down icon 0.14%
diagnostics_research MTD
$1,243.94
price up icon 0.98%
diagnostics_research IQV
$183.93
price up icon 0.65%
大文字化:     |  ボリューム (24 時間):